01 DOSE ESCALATION WITH ORIGINATOR INFLIXIMAB IS MORE COMMON THAN STANDARD DOSING IN PEDIATRIC IBD – THE DEVELOP EXPERIENCE
Griffiths, Anne, Escher, Johanna, Izanec, James, Busse, Christopher, Wang, Yanli, Dubinsky, MarlaVolume:
156
Language:
english
Journal:
Gastroenterology
DOI:
10.1053/j.gastro.2019.01.098
Date:
February, 2019
File:
PDF, 647 KB
english, 2019